PH27292A - 6-methodxy-9(2-o-pentanoyl-beta-d-arabinofuranosyl)-9H-purine - Google Patents

6-methodxy-9(2-o-pentanoyl-beta-d-arabinofuranosyl)-9H-purine

Info

Publication number
PH27292A
PH27292A PH39191A PH39191A PH27292A PH 27292 A PH27292 A PH 27292A PH 39191 A PH39191 A PH 39191A PH 39191 A PH39191 A PH 39191A PH 27292 A PH27292 A PH 27292A
Authority
PH
Philippines
Prior art keywords
methodxy
arabinofuranosyl
pentanoyl
purine
beta
Prior art date
Application number
PH39191A
Other languages
English (en)
Inventor
Thomas Anthony Krenitsky
George Walter Koszalka
Linda Addington Jones
Devron Randolph Averett
Allan Ray Moorman
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of PH27292A publication Critical patent/PH27292A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Plant Substances (AREA)
PH39191A 1987-05-30 1989-09-01 6-methodxy-9(2-o-pentanoyl-beta-d-arabinofuranosyl)-9H-purine PH27292A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB878712745A GB8712745D0 (en) 1987-05-30 1987-05-30 Antiviral compounds
PH3698488 1988-05-27

Publications (1)

Publication Number Publication Date
PH27292A true PH27292A (en) 1993-05-04

Family

ID=10618179

Family Applications (1)

Application Number Title Priority Date Filing Date
PH39191A PH27292A (en) 1987-05-30 1989-09-01 6-methodxy-9(2-o-pentanoyl-beta-d-arabinofuranosyl)-9H-purine

Country Status (31)

Country Link
US (2) US5424295A (fr)
EP (1) EP0294114B1 (fr)
JP (1) JP2667873B2 (fr)
KR (1) KR970009474B1 (fr)
CN (1) CN1020107C (fr)
AT (1) ATE142636T1 (fr)
AU (1) AU622403B2 (fr)
CA (1) CA1330990C (fr)
CS (1) CS277006B6 (fr)
CY (2) CY2001A (fr)
DD (2) DD282694A5 (fr)
DE (2) DE122008000003I2 (fr)
DK (1) DK171670B1 (fr)
ES (1) ES2091750T3 (fr)
FI (1) FI89805C (fr)
GB (1) GB8712745D0 (fr)
GR (1) GR3021257T3 (fr)
HK (1) HK78497A (fr)
HU (2) HU205001B (fr)
IL (1) IL86531A (fr)
LU (1) LU91370I2 (fr)
MC (1) MC1935A1 (fr)
MY (1) MY103567A (fr)
NL (1) NL300302I2 (fr)
NO (2) NO172543C (fr)
NZ (1) NZ224813A (fr)
PH (1) PH27292A (fr)
PL (1) PL157684B1 (fr)
PT (1) PT87592B (fr)
SA (1) SA99200688A (fr)
ZA (2) ZA883829B (fr)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8712745D0 (en) * 1987-05-30 1987-07-01 Wellcome Found Antiviral compounds
US6060459A (en) * 1987-10-28 2000-05-09 Pro-Neuron, Inc. Enhancing blood cell count with oxypurine nucleosides
DD293498A5 (de) * 1989-07-20 1991-09-05 Zi Fuer Molekularbiologie Der Adw,De Verfahren zur herstellung eines mittels fuer die behandlung oder prophylaxe von hepatits-infektionen bei mensch und tier
GB8919607D0 (en) * 1989-08-30 1989-10-11 Wellcome Found Novel entities for cancer therapy
US6337209B1 (en) 1992-02-26 2002-01-08 Glaxo Wellcome Inc. Molecular constructs containing a carcinoembryonic antigen regulatory sequence
KR910007655A (ko) * 1989-10-03 1991-05-30 엠. 피. 잭슨 치료용 뉴클레오시드
US5206351A (en) * 1990-06-15 1993-04-27 Ash Stevens, Inc. Process for the preparation of 2-amino (2,3,5-tri-o-benzyl-beta-d-arabinofuranosyl)adenine
GB9015914D0 (en) * 1990-07-19 1990-09-05 Wellcome Found Heterocyclic compounds
US5283331A (en) * 1990-12-20 1994-02-01 Nippon Kayaku Kabushiki Kaisha 2-halogeno-oxetanocin A and phosphoric ester thereof
GB9104165D0 (en) * 1991-02-27 1991-04-17 Wellcome Found Novel entities for hiv therapy
US5961987A (en) * 1996-10-31 1999-10-05 University Of Iowa Research Foundation Ocular protein stimulants
JP3619017B2 (ja) 1998-06-24 2005-02-09 日本臓器製薬株式会社 新規アラビノシルアデニン誘導体
US6653318B1 (en) 1999-07-21 2003-11-25 Yale University 5-(E)-Bromovinyl uracil analogues and related pyrimidine nucleosides as anti-viral agents and methods of use
WO2001060383A1 (fr) * 2000-02-18 2001-08-23 Southern Research Institute Procedes de synthese de 2-chloro-9-(2-deoxy-2-fluoro-$g(b)-d-arabinofuranosyl)-9h-purine-6-amine
US6753322B2 (en) * 2000-06-06 2004-06-22 Pfizer Inc 2-aminocarbonyl-9H-purine derivatives
JP3421330B2 (ja) * 2000-11-02 2003-06-30 持田製薬株式会社 ビダラビン注射用乾燥製剤
US6924271B2 (en) * 2001-11-27 2005-08-02 Anadys Pharmaceuticals, Inc. 3-β-D-ribofuranosylthiazolo[4-5-d]pyridimine nucleosides and uses thereof
US7321033B2 (en) * 2001-11-27 2008-01-22 Anadys Pharmaceuticals, Inc. 3-B-D-ribofuranosylthiazolo [4,5-d] pyrimidine nucleosides and uses thereof
PL376043A1 (en) * 2002-09-30 2005-12-12 Genelabs Technologies, Inc. Nucleoside derivatives for treating hepatitis c virus infection
KR101320008B1 (ko) * 2004-12-17 2013-10-18 애나디스 파마슈티칼스, 인코포레이티드 ３，５-이치환 및 ３，５，７-삼치환된-３Ｈ-옥사졸로 및３Ｈ-티아졸로 〔４，５-ｄ〕피리미딘-2-온 화합물 및 이의전구약물
US20060178512A1 (en) * 2005-02-04 2006-08-10 Cheruthur Govindan Method for preparing amino acid esters of nucleoside analogues
TWI383987B (zh) 2005-11-21 2013-02-01 Anadys Pharmaceuticals Inc 製備５-胺基-３Ｈ-噻唑并〔４，５-ｄ〕嘧啶-２-酮之新穎方法
JP5345527B2 (ja) * 2006-06-22 2013-11-20 アナディス ファーマシューティカルズ インク プロドラッグである５−アミノ−３−（３’−デオキシ−β−Ｄ−リボフラノシル）−チアゾロ［４，５−ｄ］ピリミジン−２，７−ジオン
WO2008011406A2 (fr) 2006-07-18 2008-01-24 Anadys Pharmaceuticals, Inc. Promédicaments à groupes fonctionnels carbonate et carbamate de thiazolo [4,5-d] pyrimidines
CN101092441A (zh) * 2007-07-17 2007-12-26 北京本草天源药物研究院 一种奈拉滨的合成方法
US7846912B2 (en) * 2007-09-13 2010-12-07 Protia, Llc Deuterium-enriched nelarabine
CN101768197A (zh) * 2008-12-29 2010-07-07 北京德众万全药物技术开发有限公司 一种奈拉滨的制备方法
CN103665076B (zh) * 2012-08-30 2018-01-09 上海阳帆医药科技有限公司 奈拉滨的制备方法
CN104892709B (zh) * 2015-06-04 2018-01-19 新乡学院 一种合成奈拉滨的方法
WO2018133835A1 (fr) * 2017-01-20 2018-07-26 National Institute Of Biological Sciences, Beijing Analogue nucléosidique régulant le rythme circadien d'un mammifère
WO2022258014A1 (fr) * 2021-06-09 2022-12-15 正大天晴药业集团股份有限公司 Bactéries génétiquement modifiées recombinées pour la préparation de nélarabine, et leur application

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE759011A (fr) * 1969-11-17 1971-05-17 Wellcome Found Aminopurines
US3758684A (en) * 1971-09-07 1973-09-11 Burroughs Wellcome Co Treating dna virus infections with amino purine derivatives
US4055717A (en) * 1976-05-17 1977-10-25 Parke, Davis & Company 9-(3-O-Acyl-β-D-arabinofuranosyl)adenine compounds, 9-(2,3-di-O-acyl-β-D-arabinofuranosyl)-adenine compounds, and method for their production
US4048432A (en) * 1976-05-17 1977-09-13 Parke, Davis & Company 9-(3,5-Di-O-acyl-β-D-arabinofuranosyl)adenine compounds and method for their production
US4055718A (en) * 1976-05-17 1977-10-25 Parke, Davis & Company 9-(2-O-Acyl-β-D-arabinofuranosyl)-adenine compounds and method for their production
JPS5515716A (en) * 1978-07-18 1980-02-04 Ajinomoto Co Inc Production of purine arabinoside
US4371613A (en) * 1977-08-10 1983-02-01 Ajinomoto Company Incorporated Method for producing purine arabinosides
JPS6053941B2 (ja) * 1977-08-10 1985-11-28 日本電気株式会社 バイアスライト駆動方式
GB1573777A (en) * 1977-11-03 1980-08-28 Wellcome Found 9-d-arabinonucleosides and an enzymatic process for their preparation
US4495180A (en) * 1982-06-21 1985-01-22 Merck & Co., Inc. Prodrugs of Ara-A an antiviral agent
JPS58225097A (ja) * 1982-06-23 1983-12-27 Yamasa Shoyu Co Ltd ヌクレオシド５′−アルキルもしくはアルケニルりん酸
EP0199451B1 (fr) * 1985-03-16 1996-03-06 The Wellcome Foundation Limited Nucléosides thérapeutiques
GB8712745D0 (en) * 1987-05-30 1987-07-01 Wellcome Found Antiviral compounds

Also Published As

Publication number Publication date
EP0294114A3 (fr) 1990-01-24
AU1671888A (en) 1988-12-01
CS277006B6 (en) 1992-11-18
MC1935A1 (fr) 1989-05-19
HK78497A (en) 1997-06-20
ZA897598B (en) 1990-01-31
DK171670B1 (da) 1997-03-10
US5539098A (en) 1996-07-23
DK289788D0 (da) 1988-05-27
SA99200688A (ar) 2005-12-03
NO882357D0 (no) 1988-05-27
FI882511A (fi) 1988-12-01
DE122008000003I1 (de) 2008-04-17
PT87592B (pt) 1992-09-30
NO882357L (no) 1988-12-01
CY2008001I2 (el) 2009-11-04
PL272729A1 (en) 1989-02-06
ES2091750T3 (es) 1996-11-16
CN1020107C (zh) 1993-03-17
CN1031233A (zh) 1989-02-22
PT87592A (pt) 1989-05-31
DE122008000003I2 (de) 2010-02-04
HU199870B (en) 1990-03-28
IL86531A (en) 1993-07-08
ATE142636T1 (de) 1996-09-15
NL300302I2 (nl) 2008-05-01
AU622403B2 (en) 1992-04-09
LU91370I2 (fr) 2007-12-10
CY2008001I1 (el) 2009-11-04
EP0294114B1 (fr) 1996-09-11
CS8803635A2 (en) 1990-09-12
EP0294114A2 (fr) 1988-12-07
NO172543B (no) 1993-04-26
IL86531A0 (en) 1988-11-15
HU895829D0 (en) 1990-01-28
JP2667873B2 (ja) 1997-10-27
KR970009474B1 (ko) 1997-06-13
NO2007016I2 (no) 2008-06-23
HU205001B (en) 1992-03-30
ZA883829B (en) 1990-01-31
DD293962A5 (de) 1991-09-19
CA1330990C (fr) 1994-07-26
GB8712745D0 (en) 1987-07-01
HUT47129A (en) 1989-01-30
PL157684B1 (pl) 1992-06-30
GR3021257T3 (en) 1997-01-31
CY2001A (en) 1997-12-05
NO172543C (no) 1993-08-04
MY103567A (en) 1993-08-28
NL300302I1 (nl) 2008-01-02
US5424295A (en) 1995-06-13
FI89805B (fi) 1993-08-13
DK289788A (da) 1988-12-01
DD282694A5 (de) 1990-09-19
DE3855522D1 (de) 1996-10-17
NZ224813A (en) 1991-04-26
JPS63310831A (ja) 1988-12-19
NO2007016I1 (no) 2008-01-14
FI882511A0 (fi) 1988-05-27
DE3855522T2 (de) 1997-02-06
FI89805C (fi) 1993-11-25
KR880013967A (ko) 1988-12-22

Similar Documents

Publication Publication Date Title
PH27292A (en) 6-methodxy-9(2-o-pentanoyl-beta-d-arabinofuranosyl)-9H-purine
MY103760A (en) Therapeutic nucleosides
CY2058B1 (en) Antiviral pyrimidine and purine compounds process for their preparation and pharmaceutical compositions containing them
AU581329B2 (en) Antiviral compounds
HU896136D0 (en) Process for producing compounds with antiviral effect and pharmaceutical compositions comprising same